FHI (FHI) Rule 144 filing details planned sale of 5,000 shares

Rhea-AI Filing Summary

FHI filed a Rule 144 notice covering the planned sale of 5,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $261,192.00. The filing notes that 77,537,867 shares of the issuer’s common stock were outstanding and that the approximate sale date is 12/12/2025 on the NYSE. The shares to be sold were acquired as restricted stock vesting under a registered plan in several grants between 11/18/2024 and 11/18/2025 in exchange for services rendered. During the past three months, Dolores Dudiak sold 999 common shares for gross proceeds of $47,824.53.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	261192.00	77537867	12/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/18/2025	Restricted stock vesting under a registered plan	Issuer			2676	11/18/2025	Services Rendered
Common	03/03/2025	Restricted stock vesting under a registered plan	Issuer			903	03/03/2025	Services Rendered
Common	11/18/2024	Restricted stock vesting under a registered plan	Issuer			1421	11/18/2024	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DOLORES DUDIAK 1001 Liberty Avenue Pittsburgh PA 15222	Common	11/19/2025	999	47824.53

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does FHI's latest Rule 144 filing report?

The Rule 144 filing reports a planned sale of 5,000 common shares of FHI, with an aggregate market value of $261,192.00, to be executed through Morgan Stanley Smith Barney LLC.

How many FHI shares are planned to be sold and on which exchange?

The notice covers the sale of 5,000 common shares of FHI, with trading indicated on the NYSE as the named securities exchange.

How were the FHI shares in this Rule 144 notice acquired?

The shares were acquired as restricted stock vesting under a registered plan, with grants on 11/18/2025, 03/03/2025, and 11/18/2024 in exchange for services rendered.

What is the total number of FHI shares outstanding mentioned in the filing?

The filing states that 77,537,867 common shares of the issuer were outstanding at the time referenced in the notice.

Who recently sold FHI shares and in what amount under Rule 144?

Dolores Dudiak, listed with an address in Pittsburgh, PA, sold 999 common shares of FHI on 11/19/2025 for $47,824.53 in gross proceeds.

What representation does the seller make in FHI's Rule 144 notice?

The seller represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.